koman....I totally understand your decision regarding risk but NWBO management has never been upfront on enrollment numbers up until last PR on GBM trial earlier this year. They have had striking results in every trial but this obviously is different being a large Phase III trial. I still find UK making it a National Priority trial as extremely positive and an possible indicator they had to see NWBO trial data plus compassionate use cases we know they have been working with their partner clinic in Israel.
I think we will see a PR before Annual meeting on Germany or possibly DCVax Direct trial update which still showed Q4 2013 in Linda's presentation. I think they already know the if vaccine is working as it has been 6 months since Direct trial started and as Linda said "they are inundated with requests to be in the trial from patients and doctors".
I like that they are executing towards their original milestones presented earlier this year and hopefully they continue to do this going into 2014!
Management's silence could be because disgruntled investors tend to retain ambulance-chasing attorneys to get settlements after filing bogus lawsuits. Ms. Powers discretion may be for our protecfion. I think it's fair to give them the 6-8 weeks they need to compile the data before the longs change our risk assessments.
I would be more fearful of companies that are pumping their stock and not owning it. NWBO is the opposite. It is a confident silence. They will only pump the price when they need more money injected. Please sell as it will be cheaper for me to buy more shares
News 
Market Data 
Discover 
AI
